☰

Aadel A. Chaudhuri - Publications

Affiliations: 
2012 Biology California Institute of Technology, Pasadena, CA 
Tree Info Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pellini B, Szymanski J, Chin RI, Jones PA, Chaudhuri AA. Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer. Thoracic Surgery Clinics. 30: 165-177. PMID 32327175 DOI: 10.1016/J.Thorsurg.2020.01.005  0.335
2020 Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, et al. Integrating genomic features for non-invasive early lung cancer detection. Nature. 580: 245-251. PMID 32269342 DOI: 10.1038/S41586-020-2140-0  0.318
2020 Pellini B, Pejovic N, Harris P, Feng W, Usmani A, Qaium F, Fields R, Chaudhuri A. Urinary cell-free DNA analysis for tumor mutation detection in patients with oligometastatic colorectal cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E15545  0.313
2019 Samson PP, Spraker MB, Badiyan SN, Vlacich G, Robinson CG, Chaudhuri AA. Local consolidative therapy for oligometastatic non-small cell lung cancer. Journal of Thoracic Disease. 11: 5649-5651. PMID 32030290 DOI: 10.21037/Jtd.2019.11.19  0.326
2019 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/J.Gastro.2019.10.039  0.325
2019 Devarakonda S, Sankararaman S, Herzog B, Gold KA, Waqar SN, Ward JP, Raymond VM, Lanman RB, Chaudhuri AA, Owonikoko TK, Li BT, Poirier JT, Rudin CM, Govindan R, Morgensztern D. Circulating Tumor DNA Profiling in Small Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31300452 DOI: 10.1158/1078-0432.Ccr-19-0879  0.333
2019 Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, Azad TD, Dudley JC, Chaudhuri AA. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Molecular Diagnosis & Therapy. PMID 30941670 DOI: 10.1007/S40291-019-00390-5  0.31
2019 Moding E, Nabet B, Liu Y, Chabon J, Chaudhuri A, Hui A, Binkley M, He J, Qiao Y, Xu T, Yao L, Gandhi S, Liao Z, Das M, Ramchandran K, et al. Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes International Journal of Radiation Oncology*Biology*Physics. 105: S113. DOI: 10.1016/J.Ijrobp.2019.06.610  0.329
2018 Chen E, Chaudhuri A, Nabet B, Chabon J, Merriott D, Loo B, Alizadeh A, Diehn M. Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e676. DOI: 10.1016/J.Ijrobp.2018.07.1826  0.365
2018 Chaudhuri AA, Nabet BY, Merriott DJ, Jin M, Chen EL, Chabon JJ, Newman AM, Stehr H, Say C, Carter JN, Walters S, Becker H, Das M, Padda SK, Loo BW, et al. (OA02) Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 101: e1-e2. DOI: 10.1016/J.Ijrobp.2018.02.041  0.346
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.Cd-17-0716  0.353
2017 Qian Y, Zhu H, Pollom EL, Durkee BY, Chaudhuri AA, Gensheimer MF, Diehn M, Shultz DB, Loo BW. Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology. PMID 28669706 DOI: 10.1016/J.Prro.2017.04.005  0.313
2017 Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28460826 DOI: 10.1016/J.Radonc.2017.03.021  0.306
2017 Chaudhuri A, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Carter JN, Merriott DJ, Liu CL, Kurtz DM, Dudley JC, Padda SK, Shrager JB, Neal JW, Wakelee HA, et al. Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies. Journal of Clinical Oncology. 35: 8519-8519. DOI: 10.1200/Jco.2017.35.15_Suppl.8519  0.352
2017 Azad TD, Chaudhuri A, Newman AM, Stehr H, Schroers-Martin J, Chabon JJ, Fang P, Qiao Y, Liao ZX, Komaki R, Alizadeh AA, Lin SH, Diehn M. Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. Journal of Clinical Oncology. 35: 4055-4055. DOI: 10.1200/Jco.2017.35.15_Suppl.4055  0.303
2017 Jeong Y, Hoang N, Stehr H, Lovejoy A, Gentles A, Chaudhuri A, Loo B, Alizadeh A, Diehn M. Abstract 1034: Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance Cancer Research. 77: 1034-1034. DOI: 10.1158/1538-7445.Am2017-1034  0.359
2017 Chabon J, Chaudhuri A, Azad T, Kurtz D, Stehr H, Liu C, Martin JS, Merriott D, Carter J, Ayers K, Mansfield A, Jen J, Ren H, West R, Nair V, et al. MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA Journal of Thoracic Oncology. 12: S1851. DOI: 10.1016/J.Jtho.2017.09.560  0.313
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Say C, Carter J, Zhou L, West R, Shrager J, Neal J, Wakelee H, Loo B, Alizadeh A, Diehn M. MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer Journal of Thoracic Oncology. 12: S445. DOI: 10.1016/J.Jtho.2016.11.520  0.329
2017 Chaudhuri A, Chabon J, Lovejoy A, Newman A, Stehr H, Azad T, Carter J, Merriott D, Liu C, Kurtz D, Gensheimer M, Shrager J, Wakelee H, Neal J, Loo B, et al. Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S114. DOI: 10.1016/J.Ijrobp.2017.06.269  0.327
2017 Merriott D, Chaudhuri A, Jin M, Chabon J, Newman A, Stehr H, Say C, Carter J, Walters S, Becker H, Das M, Padda S, Loo B, Wakelee H, Neal J, et al. Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S20-S21. DOI: 10.1016/J.Ijrobp.2017.06.061  0.326
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Merriott D, Carter J, Azad T, Padda S, Gensheimer M, Wakelee H, Neal J, Loo B, Alizadeh A, Diehn M. Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome International Journal of Radiation Oncology*Biology*Physics. 99: S1-S2. DOI: 10.1016/J.Ijrobp.2017.06.021  0.345
2016 Chaudhuri AA, Lovejoy AF, Chabon JJ, Newman A, Stehr H, Say C, Aggarwal S, Carter JN, West RB, Neal JW, Wakelee HA, Loo BW, Alizadeh A, Diehn M. CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S41-S42. PMID 27675925 DOI: 10.1016/J.Ijrobp.2016.06.112  0.35
2016 Binkley MS, King M, Bush K, Shrager JB, Chaudhuri AA, Popat R, Maxim PG, Guo HH, Diehn M, Nair VS, Loo BW. Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E456-E457. PMID 27674740 DOI: 10.1016/J.Ijrobp.2016.06.1776  0.311
2016 Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. PMID 27663899 DOI: 10.1158/2159-8290.Cd-16-0127  0.356
2016 Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology (London, England). 11: 40. PMID 26975700 DOI: 10.1186/S13014-016-0616-8  0.313
2015 Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology. 25: 305-12. PMID 26384278 DOI: 10.1016/J.Semradonc.2015.05.001  0.322
2015 Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer (Amsterdam, Netherlands). 89: 50-6. PMID 25997421 DOI: 10.1016/J.Lungcan.2015.04.014  0.324
2015 Binkley M, Shrager J, Chaudhuri A, Popat R, Maxim P, Shultz D, Diehn M, Loo B. Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 93: E424. DOI: 10.1016/J.Ijrobp.2015.07.1628  0.322
2014 Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics. 90: 216-23. PMID 25015205 DOI: 10.1016/J.Ijrobp.2014.05.025  0.324
2014 So AY, Sookram R, Chaudhuri AA, Minisandram A, Cheng D, Xie C, Lim EL, Flores YG, Jiang S, Kim JT, Keown C, Ramakrishnan P, Baltimore D. Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. Blood. 124: 1502-12. PMID 25006123 DOI: 10.1182/Blood-2014-02-553842  0.616
2014 Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, Wang J. MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene. 33: 5332-40. PMID 24213572 DOI: 10.1038/onc.2013.478  0.338
2014 Chaudhuri AA, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Abstract 864: Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors Cancer Research. 74: 864-864. DOI: 10.1158/1538-7445.Am2014-864  0.336
2014 Chaudhuri A, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S78-S79. DOI: 10.1016/J.Ijrobp.2014.08.325  0.328
2014 Chaudhuri A, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S160. DOI: 10.1016/J.Ijrobp.2014.05.651  0.328
2014 Chaudhuri A, So A, Sookram R, Baltimore D. MicroRNA-125b Represses IRF4 to Induce Acute Myeloid Leukemia International Journal of Radiation Oncology*Biology*Physics. 90: S770-S771. DOI: 10.1016/J.Ijrobp.2014.05.2230  0.428
2013 Hu R, Huffaker TB, Kagele DA, Runtsch MC, Bake E, Chaudhuri AA, Round JL, O'Connell RM. MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression. Journal of Immunology (Baltimore, Md. : 1950). 190: 5972-80. PMID 23686497 DOI: 10.4049/Jimmunol.1300351  0.41
2012 Chaudhuri AA, So AY, Mehta A, Minisandram A, Sinha N, Jonsson VD, Rao DS, O'Connell RM, Baltimore D. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proceedings of the National Academy of Sciences of the United States of America. 109: 4233-8. PMID 22366319 DOI: 10.1073/Pnas.1200677109  0.65
2011 Chaudhuri AA, So AY, Sinha N, Gibson WS, Taganov KD, O'Connell RM, Baltimore D. MicroRNA-125b potentiates macrophage activation. Journal of Immunology (Baltimore, Md. : 1950). 187: 5062-8. PMID 22003200 DOI: 10.4049/Jimmunol.1102001  0.556
2010 O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 33: 607-19. PMID 20888269 DOI: 10.1016/J.Immuni.2010.09.009  0.648
2010 O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proceedings of the National Academy of Sciences of the United States of America. 107: 14235-40. PMID 20660734 DOI: 10.1073/Pnas.1009798107  0.692
2010 Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity. 33: 48-59. PMID 20598588 DOI: 10.1016/J.Immuni.2010.06.013  0.642
2010 O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nature Reviews. Immunology. 10: 111-22. PMID 20098459 DOI: 10.1038/Nri2708  0.598
2009 O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences of the United States of America. 106: 7113-8. PMID 19359473 DOI: 10.1073/Pnas.0902636106  0.648
2008 O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. The Journal of Experimental Medicine. 205: 585-94. PMID 18299402 DOI: 10.1084/Jem.20072108  0.649
2007 Rao DS, O’Connell RM, Chaudhuri AA, Boldin M, Taganov K, Nicoll J, Paquette R, Baltimore D. MicroRNA-155 Promotes Myeloid Proliferation and Is Overexpressed in Acute Myeloid Leukemia. Blood. 110: 715-715. DOI: 10.1182/Blood.V110.11.715.715  0.66
2004 Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, Chaudhuri A, Farzan-Kashani R, Zuker M, Pasquinelli AE, Ruvkun G, Sharp PA, Tabin CJ, McManus MT. MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nature Genetics. 36: 1079-83. PMID 15361871 DOI: 10.1038/Ng1421  0.389
Show low-probability matches.